The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Association of Surgery With Improved Survival in Stage IV Breast Cancer Patients
Abstract
OBJECTIVE: This study aims to examine the role of surgery in patients with stage IV breast cancer. BACKGROUND: Historically, women who present with metastatic breast cancer are not offered surgical treatment. However, recent reports indicate that surgery may improve outcome. Using a large database of women whom presented with stage IV breast cancer, we compared outcome of patients who had resection of their primary cancer to those who did not. METHODS: Of 16,401 patients, 807 had stage IV disease at presentation, and 395 survived >90 days and were included in this analysis. Clinical and tumor characteristics, surgical treatment, and survival were compared for the surgically versus nonsurgically treated patients. RESULTS: Two hundred and forty-two patients (61.3%) had definitive surgery for their primary tumor and 153 (38.7%) did not. Patients who underwent surgery were significantly older, were more likely to be white, more often had hormone receptor positive disease, had small primary tumors, and had fewer metastatic sites and less visceral involvement. The median survival of surgically treated patients was 27.1 months versus 16.8 months for patients without surgical resection (P < 0.0001). In multivariate analysis, which included surgical treatment, age, race, estrogen and progesterone receptor status, number of metastatic sites, and presence of visceral metastases, surgery remained an independent factor associated with improved survival (P = 0.006). CONCLUSION: Patients with stage IV breast cancer who had definitive surgical treatment of their primary tumors had more favorable disease characteristics. However, after adjustment for these characteristics, surgical treatment remained an independent factor associated with improved survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overgaard, M., Hansen, P. S., Overgaard, J., Rose, C., Andersson, M., Bach, F., Kjaer, M., Gadeberg, C. C., Mouridsen, H. T., Jensen, M.-B., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371401 · Cited by 2,554
Adjuvant Radiotherapy and Chemotherapy in Node-Positive Premenopausal Women with Breast Cancer
Ragaz, J., Jackson, S. M., Le, N., Plenderleith, I. H., Spinelli, J. J., Basco, V. E., Wilson, K. S., Knowling, M. A., Coppin, C. M. L., Paradis, M., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371402 · Cited by 1,745
Flanigan, R. C., Salmon, S. E., Blumenstein, B. A., Bearman, S. I., Roy, V., McGrath, P. C., Caton, J. R., Munshi, N., & Crawford, E. D. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003013 · Cited by 1,715
Elledge, R. M., Clark, G. M., Chamness, G. C., & Osborne, C. K. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.9.705 · Cited by 414
Self-citationRapiti, E., Verkooijen, H. M., Vlastos, G., Fioretta, G., Neyroud-Caspar, I., Sappino, A. P., Chappuis, P. O., & Bouchardy, C. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.2226 · Cited by 391
Does aggressive local therapy improve survival in metastatic breast cancer?
Khan, S. A., Stewart, A. K., & Morrow, M. (2002) · Surgery · doi:10.1067/msy.2002.127544 · Cited by 391
Newman, L. A., Griffith, K. A., Jatoi, I., Simon, M. S., Crowe, J. P., & Colditz, G. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.3472 · Cited by 362
Gnerlich, J., Jeffe, D. B., Deshpande, A. D., Beers, C., Zander, C., & Margenthaler, J. A. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9438-0 · Cited by 328
Babiera, G. V., Rao, R., Feng, L., Meric-Bernstam, F., Kuerer, H. M., Singletary, S. E., Hunt, K. K., Ross, M. I., Gwyn, K. M., Feig, B. W., et al. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.033 · Cited by 284
Profile of Immune Cells in Axillary Lymph Nodes Predicts Disease-Free Survival in Breast Cancer
Kohrt, H. E., Nouri, N., Nowels, K., Johnson, D., Holmes, S., & Lee, P. P. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020284 · Cited by 220
Adequate locoregional treatment for early breast cancer may prevent secondary dissemination.
Arriagada, R., Rutqvist, L. E., Mattsson, A., Kramar, A., & Rotstein, S. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.12.2869 · Cited by 202
A Role for Curative Surgery in the Treatment of Selected Patients with Metastatic Breast Cancer
Singletary, S. E., Walsh, G., Vauthey, J.-N., Curley, S., Sawaya, R., Weber, K. L., Meric, F., & Hortobágyi, G. N. (2003) · The Oncologist · doi:10.1634/theoncologist.8-3-241 · Cited by 167
Fisher, B. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00217-8 · Cited by 150
Does surgery modify growth kinetics of breast cancer micrometastases?
Demicheli, R., Valagussa, P., & Bonadonna, G. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1969 · Cited by 125
Evidence for immune defects in breast and lung cancer patients
Caraș, I., Grigorescu, A. C., Stăvaru, C., Radu, D. L., Mogos, I., Szegli, G., & Sălăgeanu, A. (2004) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0556-2 · Cited by 99
Spontaneous apoptosis of blood dendritic cells in patients with breast cancer
Pinzón‐Charry, A., Maxwell, T., McGuckin, M. A., Schmidt, C., Furnival, C. M., & López, J. A. (2005) · Breast Cancer Research · doi:10.1186/bcr1361 · Cited by 59
Woodward, W. A., Huang, E. H., McNeese, M. D., Perkins, G. H., Tucker, S. L., Strom, E. A., Middleton, L. P., Hahn, K. M. E., Hortobágyi, G. N., & Buchholz, T. A. (2006) · Cancer · doi:10.1002/cncr.22281 · Cited by 51
Down-regulation of the CD3-ζ chain in sentinel node biopsies from breast cancer patients
Schüle, J. M., Bergkvist, L., Håkansson, L., Gustafsson, B., & Håkansson, A. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1016009913699 · Cited by 32
Cited by
Badwe, R., Hawaldar, R., Nair, N., Kaushik, R., Parmar, V., Siddique, S., Budrukkar, A., Mittra, I., & Gupta, S. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00135-7 · Cited by 592
Carlson, R. W., Allred, D. C., Anderson, B. O., Burstein, H. J., Carter, W. B., Edge, S. B., Erban, J. K., Farrar, W. B., Goldstein, L. J., Gradishar, W. J., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0012 · Cited by 450
Pagani, O., Senkus, E., Wood, W., Colleoni, M., Cufer, T., Kyriakides, S., Costa, A., Winer, E. P., Cardoso, F., & on behalf of the ESO-MBC Task Force (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq029 · Cited by 422
Survival differences among women with de novo stage IV and relapsed breast cancer
Dawood, S., Broglio, K., Ensor, J., Hortobagyi, G. N., & Giordano, S. H. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq220 · Cited by 273
Third consensus on medical treatment of metastatic breast cancer
Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., Jassem, J., Köstler, W. J., Krainer, M., Menard, S., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp261 · Cited by 263
Metadata
- Authors
- Blanchard, D. K., Shetty, P. B., Hilsenbeck, S. G., & Elledge, R. M.
- Venue
- Annals of Surgery
- Published
- 2008-05
- Volume
- 247
- Issue
- 5
- Pages
- 732-738
- ISSN
- 0003-4932 (ISSN-L)
- OpenAlex
- W2038252533
- Cited by
- 254
- References
- 19
- FWCI
- 6.77
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.